Proteomics and personalized PDX models identify treatment for a progressive malignancy within an actionable timeframe
Georgina D. Barnabas(University of British Columbia), Philipp F. Lange(University of British Columbia Hospital)
Cited by 3
Related Papers
Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression
|Cancer Research|2021|54
PDX models reflect the proteome landscape of pediatric acute lymphoblastic leukemia but divert in select pathways
|Journal of Experimental & Clinical Cancer Research|2021|24
ASAP─Automated Sonication-Free Acid-Assisted Proteomes─from Cells and FFPE Tissues
|Analytical Chemistry|2023|14